Bio is the infrastructure for a new scientific economy. We enable global communities of scientists, patients, funders, and builders to create open, user-owned research networks that fund and develop science from day one.

It costs about $2.5 billion to bring a drug to market, and scientists still wait months or years for capital that funds overhead instead of experiments.

Science should behave like software: fundable, ownable, composable. Instead breakthroughs stay locked in silos: paywalled papers, private labs, and tools that never talk.

Even when the science works, products and treatments start from scratch. Bio brings science onchain so discovery does not stop at the lab door.

Bio helps scientists raise funds, accelerate research with AI they steer, earn credibility through scientific review, and share the value their work creates. Funding follows proof — capital backs science that is moving forward, and value flows back to the people who made it.

Bio is a new financial layer for funding and developing early-stage biotech. Our mission is to reshape how biotech breakthroughs are born by enabling global communities of patients, researchers and crypto users to create user-owned research networks that fund and develop new and emerging biotechnologies from day one​.

At its core, Bio is designed to help scientists raise funds for their research, create value from that research, and capture and distribute that value via commercial successes.

By breaking down traditional biotech barriers and introducing a permissionless framework, Bio can accelerate life-saving discoveries while making them more accessible to all.